We report the results of an interdisciplinary collaboration formed to assess the sterilizing capabilities of the One Atmosphere Uniform Glow Discharge Plasma (OAUGDP). This newly-invented source of glow discharge plasma (the fourth state of matter) is capable of operating at atmospheric pressure in air and other gases, and of providing antimicrobial active species to surfaces and workpieces at room temperature as judged by viable plate counts. OAUGDP exposures have reduced log numbers of bacteria, Staphylococcus aureus and Escherichia coli, and endospores from Bacillus stearothermophilus and Bacillus subtilis on seeded solid surfaces, fabrics, filter paper, and powdered culture media at room temperature. Initial experimental data showed a two-log10 CFU reduction of bacteria when 2 x 10(2) cells were seeded on filter paper. Results showed > or = 3 log10 CFU reduction when polypropylene samples seeded with E. coli (5 x 10(4)) were exposed, while a 30 s exposure time was required for similar killing with S. aureus-seeded polypropylene samples. The exposure times required to effect > or = 6 log10 CFU reduction of E. coli and S. aureus on polypropylene samples were no longer than 30 s. Experiments with seeded samples in sealed commercial sterilization bags showed little or no differences in exposure times compared to unwrapped samples. Plasma exposure times of less than 5 min generated > or = 5 log10 CFU reduction of commercially prepared Bacillus subtilis spores (1 x 10(5)); 7 min OAUGDP exposures were required to generate a > or = 3 log10 CFU reduction for Bacillus stearothermophilus spores. For all microorganisms tested, a biphasic curve was generated when the number of survivors vs time was plotted in dose-response cures. Several proposed mechanisms of killing at room temperature by the OAUGDP are discussed.
A study was conducted to determine the effect of one atmosphere uniform glow discharge plasma (OAUGDP) on inactivation of Escherichia coli O157:H7, Salmonella, and Listeria monocytogenes on apples, cantaloupe, and lettuce, respectively. A five-strain mixture of cultured test organisms was washed, suspended in phosphate buffer, and spot inoculated onto produce (7 log CFU per sample). Samples were exposed inside a chamber affixed to the OAUGDP blower unit operated at a power of 9 kV and frequency of 6 kHz. This configuration allows the sample to be placed outside of the plasma generation unit while allowing airflow to carry the antimicrobial active species, including ozone and nitric oxide, onto the food sample. Cantaloupe and lettuce samples were exposed for 1, 3, and 5 min, while apple samples were exposed for 30 s, 1 min, and 2 min. After exposure, samples were pummeled in 0.1% peptone water-2% Tween 80, diluted, and plated in duplicate onto selective media and tryptic soy agar and incubated as follows: E. coli O157:H7 (modified eosin methylene blue) and Salmonella (xylose lysine tergitol-4) for 48 h at 37 degrees C, and L. monocytogenes (modified Oxford medium) at 48 h for 32 degrees C. E. coli O157:H7 populations were reduced by >1 log after 30-s and 1-min exposures and >2 log after a 2-min exposure. Salmonella populations were reduced by >2 log after 1 min. Three- and 5-min exposure times resulted in >3-log reduction. L. monocytogenes populations were reduced by 1 log after 1 min of exposure. Three- and 5-min exposure times resulted in >3- and >5-log reductions, respectively. This process has the capability of serving as a novel, nonthermal processing technology to be used for reducing microbial populations on produce surfaces.
The medical, industrial, and food processing industries are constantly in search of new technologies to provide improved methods of sterilization and pasteurization. Proposed techniques must deal with such problems as thermal sensitivity and destruction by heat, formation of toxic by-products, cost, and inefficiency in performance. We report results from a newly invented plasma source, a one atmosphere uniform glow discharge plasma (OAUGDP), which is capable of operating at atmospheric pressure in air and providing antimicrobial active species at room temperature. OAUGDP exposures have reduced log numbers of bacteria (Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa), bacterial endospores (Bacillus subtilis and Bacillus pumilus), and various yeast and bacterial viruses on a variety of surfaces. These surfaces included polypropylene, filter paper, paper strips, solid culture media, and glass. Experimental results showed at least a ⩾5 log10 colony forming units (CFU) reduction in bacteria within a range of 15–90 s of exposure, whether the samples were exposed in conventional sterilization bags or exposed directly to the plasma. An exception to these very short exposure times were experiments with solid culture media in which 5 min of plasma exposure was necessary to produce ⩾5 log10 CFU reduction in bacterial counts. The effects of plasma treatment on bacterial cell structures were investigated by exposing cells to plasma for various durations and examining them by transmission electron microscopy. The results showed that cell breakage (lysis) occurred with the release of cellular contents. These data were consistent with spectrophotometric results in which the release of cellular constituents was measured as a change in ultraviolet absorption at 260 nm. With all microorganisms tested, a biphasic survival curve (logarithmic number of survivors versus time) was observed in plots of dose-response data. Differences in susceptibilities of microorganisms observed on various surfaces suggested that the degree of lethality was dependent upon the time of diffusion of active species through the medium to the organism and the makeup of the microbial cellular surface.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.